Comparative Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors vs Sulfonylureas in Patients With Type 2 Diabetes

IMPORTANCE: In the treatment of type 2 diabetes, evidence of the comparative effectiveness of sodium-glucose cotransporter 2 (SGLT2) inhibitors vs sulfonylureas—the second most widely used antihyperglycemic class after metformin—is lacking. OBJECTIVE: To evaluate the comparative effectiveness of SGL...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Yan, Bowe, Benjamin, Gibson, Andrew K., McGill, Janet B., Maddukuri, Geetha, Al-Aly, Ziyad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240007/
https://www.ncbi.nlm.nih.gov/pubmed/34180939
http://dx.doi.org/10.1001/jamainternmed.2021.2488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240007/
https://www.ncbi.nlm.nih.gov/pubmed/34180939
http://dx.doi.org/10.1001/jamainternmed.2021.2488

Ejemplares similares